ClinConnect ClinConnect Logo
Search / Trial NCT06535022

DeliKet (Substudy of KetoNiFast Study ID 22-1398_1)

Launched by UNIVERSITY HOSPITAL OF COLOGNE · Aug 1, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Ketogenic Diet Cyclic Nutrition Postoperative Delirium

ClinConnect Summary

The DeliKet trial is studying whether a special way of feeding critically ill patients can help reduce the risk of postoperative delirium, which is a common and serious condition that can occur after surgery. The researchers want to see if giving patients a ketogenic diet, where they eat during the day and fast at night, is more effective than the usual method of continuous feeding around the clock. This ketogenic approach may help the brain recover and reduce inflammation, potentially leading to better outcomes for patients in intensive care.

To participate in this study, you must be at least 18 years old and admitted to an intensive care unit (ICU) starting on enteral nutrition (a way of feeding through a tube). However, there are some health conditions that would exclude you from the trial, such as severe liver disease or certain metabolic disorders. If you qualify, you can expect to be part of a study that aims to improve recovery after surgery, and your health will be closely monitored throughout the process. This trial is not yet recruiting participants, but it aims to provide important insights into better nutrition strategies for critically ill patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Admission to an ICU
  • Start of enteral nutrition
  • Exclusion Criteria:
  • Severe liver insufficiency / liver disease (Child Pugh \> B or 7-9 points)
  • Post total Pancreatectomy / Insulin-depending diabetes mellitus (IDDM)
  • Pregnancy / Lactation
  • Hemoglobin-concentration \< 80g/l
  • Severe metabolic disorder / severe autoimmune disease
  • Refractory respiratory or metabolic acidosis
  • Disorder of mitochondrial transportation of fatty acids
  • Disorder of the oxidation of fatty acids
  • Disorder of gluconeogenesis, der ketone body production or ketone body degradation
  • Intermittent porphyria
  • Severe arrhythmia / cardiomyopathy
  • Contraindications against enteral nutrition
  • Missing informed consent

About University Hospital Of Cologne

The University Hospital of Cologne is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields, collaborating with multidisciplinary teams to conduct rigorous investigations that enhance patient care and contribute to the development of new therapeutic strategies. With state-of-the-art facilities and a strong emphasis on education and training, the University Hospital of Cologne is dedicated to fostering a collaborative environment that promotes ethical research practices and improves health outcomes for diverse patient populations.

Locations

Patients applied

0 patients applied

Trial Officials

Bernd W Böttiger, Prof

Study Director

University Hospital Cologne

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported